GlassScriptPhysician profile
Tiffany Cheng
NPI 1730746488
$8,536.97
in general payments reported to CMS, 2019-2025
50 companies · $335 in 2025
The $335 reported for 2025 was more than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $1,409 · 2022: $2,110 · 2023: $3,451 · 2024: $1,233 · 2025: $335.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $5,019 · Education: $0.15.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $5,018.73 |
| Education | $0.15 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Antares Pharma, INC. | $1,122.48 | 2021-2024 | Xyosted, Tlando, Nocdurna |
| Abbott Laboratories | $798.40 | 2023-2025 | Freestyle Libre 3, Freestyle Libre 2 |
| Corcept Therapeutics | $750.16 | 2021-2025 | Korlym |
| Lilly USA, LLC | $719.37 | 2021-2024 | Mounjaro, Jardiance, Trulicity |
| Amgen INC. | $696.54 | 2021-2023 | Evenity, Prolia, Repatha |
| Mannkind Corporation | $445.25 | 2021-2023 | Afrezza |
| Otsuka America Pharmaceutical, INC. | $323.22 | 2022-2024 | Jynarque, Abilify Maintena |
| Abbvie INC. | $320.93 | 2021-2024 | |
| Halozyme INC | $256.35 | 2023 | |
| Xeris Pharmaceuticals, INC. | $227.95 | 2022-2024 | Recorlev, Gvoke Hypopen, Keveyis |
| Dexcom, INC. | $225.19 | 2022-2024 | Dexcom G7 Gss (161), Dexcom G6 Transmitter |
| Tolmar, INC. | $185.47 | 2023-2024 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $182.00 | 2021-2023 | Jardiance, Synjardy |
| Beta Bionics, INC. | $178.72 | 2024 | Ilet Bionic Pancreas |
| Cequr Corporation | $162.06 | 2022-2023 | Cequr Simplicity |
Show all 50 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Tiffany Cheng listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.